Vektor Medical, a San Diego, CA-based non-invasive, AI-based arrhythmia analysis technology, has raised $16 million in Series A funding.

SaaS Investors

The round was co-led by Solas BioVentures and TVM Capital Life Science.

Solas BioVentures invests exclusively in the life science industry, focusing on early-stage biotech, medtech, and digital health companies. Founded in Chattanooga, TN, Solas is proud of its southern roots and founder-centric patient-focused approach to foster breakthrough medicine and technology innovation.

TVM Capital Life Science is a leading international venture capital firm focused on investing in life science innovations. The company has approximately $900 million under management. TVM’s portfolio focuses on therapeutics and medical technologies from North America and the EU that represent differentiated first-in-class or best-in-class assets with the potential to transform the standard of care.

Vektor Medical Use of Funds 

The company will use the funding to support the commercialization of vMap, Vektor's AI-based arrhythmia analysis tool, which streamlines ablation procedures for electrophysiologists (EPs) and improves patient outcomes. The funds will also be used to increase clinical support, conduct additional clinical studies, and work towards securing reimbursement.

About Vektor Medical 

Vektor Medical is a medical technology company focused on non-invasive arrhythmia mapping to improve cardiac care and patient quality of life. The company is on a mission to revolutionize arrhythmia care for millions affected by atrial fibrillation and other arrhythmias. Through its AI-based, non-invasive arrhythmia analysis technology, vMap, the company aims to improve cardiac ablation outcomes, optimize workflows, and increase procedural efficiency. vMap is the only FDA-cleared, non-invasive AI-based solution for arrhythmia localization and analysis, utilizing a 12-lead ECG.  

Funding Details 

Company: Vektor Medical, Inc.    

Raised: $16.0M              

Round: Series A     

Funding Month: February 2024                  

Lead Investors: Solas BioVentures and TVM Capital Life Science  

Additional Investors:   

Company Website: https://www.vektormedical.com/   

Software Category: Medical  

Source: https://www.businesswire.com/news/home/20240205405047/en/